Li Xiangzhao, Liu Huanjiao, Liang Minyi, Chen Huihui, Liang Li
Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2020 Nov 30;40(11):1645-1650. doi: 10.12122/j.issn.1673-4254.2020.11.17.
To explore the clinicopathological features and types of genic mutations in DNA mismatch repair (MMR) in colorectal cancer (CRC).
Immunohistochemistry was used to determine the expression of MMR proteins in 1394 patients with CRC, and PCR-capillary electrophoresis (PCR-CE) was used to detect microsatellite instability (MSI) in 106 cases of defective MMR (dMMR), 46 cases of proficient MMR (pMMR) with heterogeneous expression and 147 randomly selected cases of pMMR. The relationship between the expressions of MMR proteins and the clinicopathological features of the patients was evaluated. The consistency between the results of immunohistochemistry and PCR-CE was assessed.
Immunohistochemical staining showed an incidence of dMMR of 7.6% in the patients. The main type of dMMR was co-deletion of MLH1 and PMS2, accounting for 55.7% of the total dMMR cases. The deletion of MMR proteins was significantly correlated with the patients' age, tumor location, tumor size, gross type, histological type, degree of differentiation, lymph node status and TNM stage ( < 0.05), but not with gender ( > 0.05). The total accordance rate of immunohistochemistry and PCR-CE was 98.7% in these patients.
The main type of dMMR is co-deletion of MLH1 and PMS2 in patients with colorectal cancer. dMMR colorectal cancer has typical clinicopathological features and a lower incidence in China than in Western countries. The results of immunohistochemistry and PCR-CE are highly consistent for detecting dMMR in colorectal cancer patients.
探讨结直肠癌(CRC)中DNA错配修复(MMR)基因的临床病理特征及基因突变类型。
采用免疫组织化学法检测1394例CRC患者MMR蛋白的表达,采用聚合酶链反应-毛细管电泳(PCR-CE)法检测106例错配修复缺陷(dMMR)、46例错配修复功能正常(pMMR)但表达异质性及147例随机选取的pMMR患者的微卫星不稳定性(MSI)。评估MMR蛋白表达与患者临床病理特征之间的关系。评估免疫组织化学和PCR-CE结果的一致性。
免疫组织化学染色显示患者中dMMR的发生率为7.6%。dMMR的主要类型是MLH1和PMS2共缺失,占dMMR病例总数的55.7%。MMR蛋白的缺失与患者的年龄、肿瘤部位、肿瘤大小、大体类型、组织学类型、分化程度、淋巴结状态及TNM分期显著相关(P<0.05),但与性别无关(P>0.05)。这些患者中免疫组织化学和PCR-CE的总符合率为98.7%。
结直肠癌患者dMMR的主要类型是MLH1和PMS2共缺失。dMMR结直肠癌具有典型的临床病理特征,在中国的发病率低于西方国家。免疫组织化学和PCR-CE检测结直肠癌患者dMMR的结果高度一致。